Prostate Cancer - Results from #120

Role of Chemokines and Cytokines in Prostate Cancer Skeletal Metastasis. November 27, 2024

The role of Cabazitaxel in Patients With Castration-Resistant and Osseous Metastases Prostate Cancer. A Hellenic Cooperative Oncology Group Phase II Study: Cabazitaxel in mCRPC patients with osseous metastases. November 27, 2024

Clinical characteristics and treatment of patients with small cell prostate cancer: analysis of a real-world cohort from an oncology database. November 27, 2024

Prostate Image Quality System (PI-QUAL) Version 2 - A Practical Guide. November 27, 2024

Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design. November 27, 2024

Multimodal approach to optimize biopsy decision-making for PI-RADS 3 lesions on multiparametric MRI. November 27, 2024

Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice. November 26, 2024

Racial and Ethnic Differences in Prostate Cancer Epidemiology Across Disease States in the VA. November 26, 2024

A PSMA-targeted Tri-specific Killer Engager enhances NK cell cytotoxicity against prostate cancer. November 26, 2024

Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genes. November 26, 2024

Influences on androgen deprivation therapy prescribing before surgery in high-risk prostate cancer. November 26, 2024

French AFU Cancer Committee Guidelines - Update 2024-2026: Prostate cancer - Diagnosis and management of localised disease. November 26, 2024

French AFU Cancer Committee Guidelines - Update 2024-2026: Prostate cancer - Management of metastatic disease and castration resistance. November 26, 2024

Prioritizing precision: detection of prostate cancer using mri guided fusion needle biopsy across the pennsylvania urologic regional collaborative. November 26, 2024

Discrimination against Gay and Bisexual Patients in Prostate Cancer Treatment: Results from the Restore-2 Study. November 26, 2024

Elucidating acquired PARP inhibitor resistance in advanced prostate cancer. November 26, 2024

Tumor architecture and emergence of strong genetic alterations are bottlenecks for clonal evolution in primary prostate cancer. November 25, 2024

Using a behaviour-change approach to support uptake of population genomic screening and management options for breast or prostate cancer. November 25, 2024

Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancer. November 25, 2024

PSMA Radiotheranostics in Prostate Cancer: Principles, Practice, and Future Prospects. November 25, 2024

Page 7 of 1447